KLTO Earnings — Klotho Neurosciences, Inc. Common Stock Post-ER Performance | BigEarnings
KLTO — Klotho Neurosciences, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$0.54
Market Cap$33.3M
P/E—
52W Range$0.11 – $3.91
Next Earnings2026-08-17
About Klotho Neurosciences, Inc. Common Stock
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
